vs
Cardio Diagnostics Holdings, Inc.（CDIO）与Rani Therapeutics Holdings, Inc.（RANI）财务数据对比。点击上方公司名可切换其他公司
Cardio Diagnostics Holdings, Inc.是一家专注于精准心血管医疗的企业，开发并商业化整合遗传与表观遗传技术的诊断检测产品，可早期识别冠心病、心力衰竭等心血管疾病，主要服务美国市场的医疗机构、临床实验室与患者。
Rani Therapeutics Holdings是一家临床阶段生物技术企业，专注于开发可替代注射类生物制剂的口服给药方案，核心专利技术RaniPill是一款机器人给药胶囊，可将大分子药物直接递送至肠壁，免除患者注射痛苦，针对糖尿病、自身免疫疾病、骨质疏松等慢性病患者，与多家头部药企合作推进产品管线。
CDIO vs RANI — 直观对比
营收规模更大
CDIO
是对方的Infinity倍
$0
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.6K | $0 |
| 净利润 | — | $-5.4M |
| 毛利率 | — | — |
| 营业利润率 | — | — |
| 净利率 | — | — |
| 营收同比 | -21.2% | — |
| 净利润同比 | 3.6% | 20.2% |
| 每股收益（稀释后） | — | $-0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDIORANI
| Q4 25 | $3.6K | — | ||
| Q3 25 | $2.9K | $0 | ||
| Q2 25 | $7.5K | $0 | ||
| Q1 25 | — | $172.0K | ||
| Q4 24 | $4.5K | — | ||
| Q3 24 | $6.6K | $0 | ||
| Q2 24 | $7.9K | $0 | ||
| Q1 24 | $15.9K | $0 |
净利润CDIORANI
| Q4 25 | — | — | ||
| Q3 25 | $-1.7M | $-5.4M | ||
| Q2 25 | $-1.7M | $-6.7M | ||
| Q1 25 | — | $-7.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.4M | $-6.8M | ||
| Q2 24 | $-1.3M | $-6.8M | ||
| Q1 24 | $-4.2M | $-7.5M |
营业利润率CDIORANI
| Q4 25 | — | — | ||
| Q3 25 | -59950.9% | — | ||
| Q2 25 | -22457.5% | — | ||
| Q1 25 | — | -6984.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -21412.9% | — | ||
| Q2 24 | -16295.6% | — | ||
| Q1 24 | -26105.3% | — |
净利率CDIORANI
| Q4 25 | — | — | ||
| Q3 25 | -60053.8% | — | ||
| Q2 25 | -22517.7% | — | ||
| Q1 25 | — | -4223.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -21467.6% | — | ||
| Q2 24 | -16365.9% | — | ||
| Q1 24 | -26140.0% | — |
每股收益（稀释后）CDIORANI
| Q4 25 | — | — | ||
| Q3 25 | $-0.98 | $-0.12 | ||
| Q2 25 | $-0.97 | $-0.18 | ||
| Q1 25 | — | $-0.22 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.73 | $-0.24 | ||
| Q2 24 | $-1.71 | $-0.26 | ||
| Q1 24 | $-5.93 | $-0.29 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $4.1M |
| 总债务越低越好 | — | $13.8M |
| 股东权益账面价值 | $7.0M | $-7.9M |
| 总资产 | $7.8M | $10.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CDIORANI
| Q4 25 | — | — | ||
| Q3 25 | — | $4.1M | ||
| Q2 25 | — | $10.2M | ||
| Q1 25 | — | $10.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $6.9M |
总债务CDIORANI
| Q4 25 | — | — | ||
| Q3 25 | — | $13.8M | ||
| Q2 25 | — | $17.5M | ||
| Q1 25 | — | $21.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $28.8M | ||
| Q2 24 | — | $30.0M | ||
| Q1 24 | — | $30.0M |
股东权益CDIORANI
| Q4 25 | $7.0M | — | ||
| Q3 25 | $8.2M | $-7.9M | ||
| Q2 25 | $9.7M | $-5.6M | ||
| Q1 25 | — | $-3.1M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $3.7M | $3.1M | ||
| Q2 24 | $3.1M | $2.8M | ||
| Q1 24 | $3.0M | $7.4M |
总资产CDIORANI
| Q4 25 | $7.8M | — | ||
| Q3 25 | $8.8M | $10.1M | ||
| Q2 25 | $10.4M | $16.9M | ||
| Q1 25 | — | $24.1M | ||
| Q4 24 | $10.6M | — | ||
| Q3 24 | $4.5M | $43.5M | ||
| Q2 24 | $4.0M | $43.7M | ||
| Q1 24 | $4.3M | $53.5M |
负债/权益比CDIORANI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 9.21× | ||
| Q2 24 | — | 10.58× | ||
| Q1 24 | — | 4.06× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.7M | $-5.1M |
| 自由现金流经营现金流 - 资本支出 | $-5.9M | — |
| 自由现金流率自由现金流/营收 | -166361.5% | — |
| 资本支出强度资本支出/营收 | 5269.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-14.3M | — |
8季度趋势，按日历期对齐
经营现金流CDIORANI
| Q4 25 | $-5.7M | — | ||
| Q3 25 | $-1.4M | $-5.1M | ||
| Q2 25 | $-1.6M | $-5.8M | ||
| Q1 25 | — | $-8.1M | ||
| Q4 24 | $-5.0M | — | ||
| Q3 24 | $-1.2M | $-8.4M | ||
| Q2 24 | $-1.2M | $-9.0M | ||
| Q1 24 | $-1.2M | $-9.4M |
自由现金流CDIORANI
| Q4 25 | $-5.9M | — | ||
| Q3 25 | $-1.6M | — | ||
| Q2 25 | $-1.6M | $-5.8M | ||
| Q1 25 | — | $-8.2M | ||
| Q4 24 | $-5.2M | — | ||
| Q3 24 | $-1.2M | $-8.5M | ||
| Q2 24 | $-1.4M | $-9.1M | ||
| Q1 24 | $-1.3M | $-9.4M |
自由现金流率CDIORANI
| Q4 25 | -166361.5% | — | ||
| Q3 25 | -54509.7% | — | ||
| Q2 25 | -21273.1% | — | ||
| Q1 25 | — | -4767.4% | ||
| Q4 24 | -115422.6% | — | ||
| Q3 24 | -17942.3% | — | ||
| Q2 24 | -17513.3% | — | ||
| Q1 24 | -7866.9% | — |
资本支出强度CDIORANI
| Q4 25 | 5269.1% | — | ||
| Q3 25 | 5703.5% | — | ||
| Q2 25 | 250.1% | — | ||
| Q1 25 | — | 29.7% | ||
| Q4 24 | 4759.9% | — | ||
| Q3 24 | 353.3% | — | ||
| Q2 24 | 2133.4% | — | ||
| Q1 24 | 125.5% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
